POSC283 Number Needed to Treat and Incremental Costs per Responder for Biologics and Targeted Synthetic Drugs in Adult Patients with Active Psoriatic Arthritis in the Russian Federation
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.920
https://www.valueinhealthjournal.com/article/S1098-3015(21)02715-7/fulltext
Title :
POSC283 Number Needed to Treat and Incremental Costs per Responder for Biologics and Targeted Synthetic Drugs in Adult Patients with Active Psoriatic Arthritis in the Russian Federation
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02715-7&doi=10.1016/j.jval.2021.11.920
First page :
Section Title :
Open access? :
No
Section Order :
10451